Asset Management One Co. Ltd. Decreases Stock Holdings in Cardinal Health, Inc. $CAH

Asset Management One Co. Ltd. trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 0.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 135,490 shares of the company’s stock after selling 105 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Cardinal Health were worth $22,762,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. Greykasell Wealth Strategies Inc. purchased a new position in Cardinal Health during the 1st quarter valued at $26,000. Jones Financial Companies Lllp boosted its holdings in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares in the last quarter. Atlantic Edge Private Wealth Management LLC boosted its stake in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares in the last quarter. GW&K Investment Management LLC boosted its stake in Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after purchasing an additional 144 shares in the last quarter. Finally, Harbor Asset Planning Inc. bought a new position in Cardinal Health in the 2nd quarter worth about $49,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer owned 26,085 shares of the company’s stock, valued at $3,881,969.70. This represents a 61.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Jason M. Hollar sold 35,901 shares of the company’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total transaction of $5,386,586.04. Following the sale, the chief executive officer directly owned 200,000 shares of the company’s stock, valued at $30,008,000. The trade was a 15.22% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 271,676 shares of company stock worth $40,489,525. Company insiders own 0.12% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CAH. UBS Group reiterated a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Wells Fargo & Company reiterated an “overweight” rating and issued a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Robert W. Baird upped their price target on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. Leerink Partners upped their price target on shares of Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a research note on Monday, October 6th. Finally, Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a research note on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $166.00.

Cardinal Health Stock Performance

CAH opened at $161.83 on Friday. The stock has a market capitalization of $38.45 billion, a P/E ratio of 25.09, a P/E/G ratio of 1.37 and a beta of 0.71. The company’s 50-day simple moving average is $152.75 and its two-hundred day simple moving average is $152.88. Cardinal Health, Inc. has a 52-week low of $106.98 and a 52-week high of $168.44.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were given a dividend of $0.5107 per share. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio is presently 31.63%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.